|
Status |
Public on Mar 18, 2015 |
Title |
TMD8-ST-7612-1 |
Sample type |
RNA |
|
|
Source name |
TMD8 cell lines treated with ST7612AA1
|
Organism |
Homo sapiens |
Characteristics |
cell line: TMD8 cell type: lymphoma cell line treated with: ST7612AA1
|
Treatment protocol |
treatment with pan-histone deacetylase inhibitor (HDACi), a thioacetate-ω (γ-lactam amide) derivative.
|
Growth protocol |
in vitro
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA extraction was performed using a commercially available kit (RNeasy, Qiagen, Frederick,MD) according to the manufactures’ recommendations. RNA quality was confirmed based on a RNA integrity number >8 by use of an electrophoresis bioanalyzer (2100 Agilent Bioanalyser).
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared with the Ambion TotalPrep RNA Amplification Kit for Illumina arrays
|
|
|
Hybridization protocol |
Whole Genome Gene Expression Direct Hybridization
|
Scan protocol |
Illumina HiScan
|
Description |
9373549084_B
|
Data processing |
Signal calculated by GenomeStudio Data Analysis Software’s Gene Expression Module (GSGX) Version 1.5.4 (Illumina, Inc.) The data were normalised using quantile method
|
|
|
Submission date |
Oct 17, 2014 |
Last update date |
Mar 18, 2015 |
Contact name |
Francesco Bertoni |
E-mail(s) |
francesco.bertoni@ior.usi.ch
|
Phone |
+41 91 820 0367
|
Organization name |
IOR
|
Department |
Lymphoma & Genomics Research Program
|
Street address |
Via V. Vela 6
|
City |
Bellinzona |
State/province |
Ticino |
ZIP/Postal code |
6500 |
Country |
Switzerland |
|
|
Platform ID |
GPL10558 |
Series (1) |
GSE62460 |
Preclinical antitumor activity of ST7612AA1: a novel second generation oral histone deacetylase (HDAC) inhibitor |
|